ArticleMicroorganisms2025

Predictive Microbial Markers Distinguish Responders and Non-Responders to Adalimumab: A Step Toward Precision Medicine in Ulcerative Colitis.

Shaghayegh Baradaran Ghavami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.